ALK-Abello A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0061802139
DKK
251.20
-8.3 (-3.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,771.00
1,733.00
1,530.00
1,527.00
1,522.00
1,499.00
1,313.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,771.00
1,733.00
1,530.00
1,527.00
1,522.00
1,499.00
1,313.00
Raw Material Cost
543.00
553.00
487.00
532.00
506.00
545.00
471.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
4.00
25.00
0.00
7.00
25.00
Selling and Distribution Expenses
507.00
605.00
475.00
474.00
418.00
582.00
427.00
Other Expenses
15.10
18.90
14.10
12.10
12.90
16.00
8.40
Total Expenditure (Excl Depreciation)
1,201.00
1,347.00
1,107.00
1,152.00
1,053.00
1,294.00
1,007.00
Operating Profit (PBDIT) excl Other Income
570
386
423
375
469
205
306
Other Income
13.00
7.00
0.00
0.00
4.00
0.00
0.00
Operating Profit (PBDIT)
667.00
488.00
510.00
450.00
544.00
281.00
369.00
Interest
0.00
0.00
4.00
25.00
0.00
7.00
25.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,228.00
1,180.00
1,043.00
995.00
1,016.00
954.00
842.00
Depreciation
84.00
95.00
87.00
75.00
71.00
76.00
63.00
Profit Before Tax
583.00
393.00
419.00
350.00
473.00
198.00
281.00
Tax
146.00
127.00
105.00
87.00
119.00
28.00
69.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
437.00
266.00
314.00
263.00
354.00
170.00
212.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
437.00
266.00
314.00
263.00
354.00
170.00
212.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
437.00
266.00
314.00
263.00
354.00
170.00
212.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.5
0.5
0.5
0.5
0.5
0.5
0.5
Reserves
6,569.00
6,445.00
6,173.00
5,847.00
5,676.00
5,373.00
5,086.00
Earnings per share (EPS)
1.97
1.2
1.42
1.19
1.6
0.77
0.96
Diluted Earnings per share
1.97
1.2
1.42
1.19
1.6
0.77
0.96
Operating Profit Margin (Excl OI)
32.19%
22.27%
27.65%
24.56%
30.81%
13.68%
23.31%
Gross Profit Margin
37.66%
28.16%
33.07%
27.83%
35.74%
18.28%
26.2%
PAT Margin
24.68%
15.35%
20.52%
17.22%
23.26%
11.34%
16.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 16.36% vs 12.66% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 23.45% vs 52.59% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 21.11% vs 41.73% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of ALK-Abello A/S With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Net Sales
1,771.00
0
1,771.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,771.00
0
1,771.00
Raw Material Cost
543.00
0
543.00
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
507.00
0
507.00
Other Expenses
15.10
0.00
15.10
Total Expenditure (Excl Depreciation)
1,201.00
0
1,201.00
Operating Profit (PBDIT) excl Other Income
570.00
0.00
570.00
Other Income
13.00
0
13.00
Operating Profit (PBDIT)
667.00
0
667.00
Interest
0.00
0
0.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,228.00
0
1,228.00
Depreciation
84.00
0
84.00
Profit Before Tax
583.00
0
583.00
Tax
146.00
0
146.00
Provisions and contingencies
0
0
0.00
Profit After Tax
437.00
0
437.00
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
437.00
0
437.00
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
437.00
0
437.00
Equity Capital
0
0
0.00
Face Value
0.50
0
0.00
Reserves
6,569.00
0
6,569.00
Earnings per share (EPS)
1.97
0
1.97
Diluted Earnings per share
1.97
0
1.97
Operating Profit Margin (Excl OI)
32.19%
0%
0.00
32.19%
Gross Profit Margin
37.66%
0%
0.00
37.66%
PAT Margin
24.68%
0%
0.00
24.68%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 177.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 2.19% vs 13.27% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16.36% vs 12.66% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 43.70 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 64.29% vs -15.29% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 23.45% vs 52.59% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 65.40 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 35.97% vs -5.69% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.11% vs 41.73% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.19%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025